Summa Equity has announced its investment in fish health supplier STIM AS.
Summa Equity
Summa Equity has announced its investment in fish health supplier STIM AS as well as partnering with its founder Jim-Roger Nordly. According to a press release published by the investment firm, this partnership aims to "establish new growth verticals, intensify product development, and expand its service offering in aquaculture worldwide."
In this line, Martin Gjølme, Partner at Summa explained which was its motivation: "Aquaculture faces challenges related to fish welfare and mortality. Solving these challenges through disease prevention, sound production protocols, genetics, and nutrition will be key to unlocking the industry's full potential. STIM is ideally positioned to take the lead role in that transformation."
In addition, Nordly recalled how the demand for advisory services is increasing: "With Summa on our side, I am confident that STIM can become the world leader within sustainability and health, not just within the salmon industry, but for the seafood industry as a whole."
The combination of STIM's fish health and biology expertise and Summa's trajectory in the aquaculture industry, proves that Summa "can be a true partner in solving some of the largest challenges the industry is facing," added Gjølme.
The UN Sustainable Development Goal #2.4 (‘Zero Hunger' – sustainable food production) and #14.4 (‘Life Under Water' - sustainable fishing) have influenced in the culmination of this agreement.
STIM AS is a quality supplier of fish health products and services, with several ground-breaking innovations under its belt. For over three decades, it has contributed to a more sustainable aquaculture industry by providing transformative innovations that improve fish health, growth, and profitability.
The company is well-positioned in several markets through its knowledgeable teams and unique cross-disciplinary competence. The gross revenue of the company was north of EUR 150m in 2023.
